S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2017

Conditions
Lymphoma
Interventions
DRUG

carmustine

150 mg/m\^2 IV over 2 hours 4, 5, and 6 days before transplant.

DRUG

cyclophosphamide

100 mg/kg IV 2 days before transplant.

DRUG

etoposide

60 mg/kg IV over 4 hours 4 days before transplant.

DRUG

melphalan

150 mg/m\^2 IV 1 day before transplant.

PROCEDURE

autologous-autologous tandem hematopoietic stem cell transplantation

2.0 x 10\^6 CD34+ cells, beginning at least 24 hours after melphalan infusion.

RADIATION

radiation therapy

150 centigray (cGy) total body irradiation given b.i.d on days 5-8 before transplant.

Trial Locations (53)

37916

Thompson Cancer Survival Center, Knoxville

60153

Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood

66720

Cancer Center of Kansas, PA - Chanute, Chanute

67042

Cancer Center of Kansas, PA - El Dorado, El Dorado

Cancer Center of Kansas, PA - Salina, Salina

67068

Cancer Center of Kansas, PA - Kingman, Kingman

67114

Cancer Center of Kansas, PA - Newton, Newton

67124

Cancer Center of Kansas, PA - Pratt, Pratt

67152

Cancer Center of Kansas, PA - Wellington, Wellington

67156

Cancer Center of Kansas, PA - Winfield, Winfield

67208

Associates in Womens Health, PA - North Review, Wichita

Cancer Center of Kansas, PA - Medical Arts Tower, Wichita

67214

Cancer Center of Kansas, PA - Wichita, Wichita

CCOP - Wichita, Wichita

Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita

67301

Cancer Center of Kansas-Independence, Independence

67357

Cancer Center of Kansas, PA - Parsons, Parsons

67801

Cancer Center of Kansas, PA - Dodge City, Dodge City

67901

Southwest Medical Center, Liberal

83712

Mountain States Tumor Institute at St. Luke's Regional Medical Center, Boise

95817

University of California Davis Cancer Center, Sacramento

97030

Legacy Mount Hood Medical Center, Gresham

97062

Legacy Meridian Park Hospital, Tualatin

97210

Legacy Good Samaritan Hospital & Comprehensive Cancer Center, Portland

97216

Adventist Medical Center, Portland

97222

Providence Milwaukie Hospital, Milwaukie

97225

CCOP - Columbia River Oncology Program, Portland

Providence St. Vincent Medical Center, Portland

97227

Legacy Emanuel Hospital and Health Center and Children's Hospital, Portland

98002

Auburn Regional Center for Cancer Care, Auburn

98003

St. Francis Hospital, Federal Way

98104

Fred Hutchinson Cancer Research Center, Seattle

Harborview Medical Center, Seattle

Minor and James Medical, PLLC, Seattle

98112

Group Health Central Hospital, Seattle

98122

Polyclinic First Hill, Seattle

98225

St. Joseph Cancer Center, Bellingham

98310

Olympic Hematology and Oncology, Bremerton

98372

Good Samaritan Cancer Center, Puyallup

98405

Allenmore Hospital, Tacoma

CCOP - Northwest, Tacoma

MultiCare Regional Cancer Center at Tacoma General Hospital, Tacoma

98499

St. Clare Hospital, Tacoma

98668

Southwest Washington Medical Center Cancer Center, Vancouver

99202

Cancer Care Northwest - Spokane South, Spokane

99336

Columbia Basin Hematology, Kennewick

71315-3198

Tulane Cancer Center Office of Clinical Research, Alexandria

97213-2967

Providence Cancer Center at Providence Portland Medical Center, Portland

98531-9027

Providence Centralia Hospital, Centralia

98506-5166

Providence St. Peter Hospital Regional Cancer Center, Olympia

98122-4307

Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle

98195-6043

University Cancer Center at University of Washington Medical Center, Seattle

98405-3004

Franciscan Cancer Center at St. Joseph Medical Center, Tacoma

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00233987 - S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter